ENTITY

Insulet Corp (PODD US)

92
Analysis
Health Care • United States
Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes.
more
bullish•ENM Holdings
•25 Sep 2023 00:21

Merger Arb Mondays (25 Sep) - ENM, Poly Culture, Eoflow, Origin Energy, Symbio, Costa, InvoCare

This week, the highest gross spreads are 111 (48.9%), Eoflow (23.7%), Symbio (10.7%), Mason Group (9.0%), JSR (7.8%), DDH1 (6.0%), ENM (5.5%),...

Logo
829 Views
Share
•21 Sep 2023 16:49

Tandem Diabetes Care (TNDM US): Q2 Sales Declined, Margin Deteriorated; 2023 Guidance Revised Lower

​Tandem's Q2 sales declined 2% YoY to $195.9M, as global pump shipment plummeted 8% YoY to 29,494. The company has lowered 2023 sales guidance to...

Logo
549 Views
Share
bullish•Insulet Corp
•15 Sep 2023 14:00

Insulet Corporation: Launch of Omnipod 5 & Other Major Developments

Insulet Corporation exceeded analyst expectations in terms of revenue as well as earnings. The company's revenue for the second quarter surpassed...

Logo
559 Views
Share
bearish•Eoflow
•11 Sep 2023 00:28

Merger Arb Mondays (11 Sep) - Eoflow, Mason, Liontown, Newcrest, United Malt, OreCorp, MPI

This week, the highest gross spreads are 111 (39.7%), Costa (22.8%), Eoflow (18.3%), Symbio (17.3%), Mason (9.0%), Origin Energy (8.1%), JSR...

Logo
667 Views
Share
bullish•JMDC
•10 Sep 2023 15:17

Weekly Deals Digest (10 Sep) - JMDC, Intage, Mason, Liontown, Newcrest, ARM, Integral, Doosan, VNG

Last week, notable developments occurred in Event-Driven (JMDC, Intage, Mason, Liontown, Newcrest, OreCorp, United Malt, MPI) and ECM (Doosan...

Logo
580 Views
Share
x